Guide

What does the research say about magnesium and migraine?

Q: How much magnesium per day was used in migraine trials?

The regimen that stands out is 600 mg of trimagnesium dicitrate daily. That is well above the 375 mg nutrient reference value and is an intervention dose used in research, not a supplement serving. Whether to use it is a clinical decision.

Q: Does magnesium stop a headache or prevent one?

The trials examined preventive use aimed at reducing attack frequency, not at stopping a headache already underway. These are different questions with different approaches.

Among the conditions magnesium has been studied in, migraine is one where the evidence is most concrete. Even so, “established” would be the wrong word.

Short answer: For the prevention of migraine attacks there is evidence at the level of “possibly effective”. Most trials are small and old; the best-supported regimen is 600 mg of trimagnesium dicitrate daily. This is preventive use aimed at attack frequency, not a way to stop a headache that has started, and it is a dose to be considered under medical supervision.

How strong is the evidence?

The most organised source is a systematic review published in Headache, which assessed five clinical trials:

Of two Class I trials, one showed a significant reduction in attack numbers compared with placebo.
Of three Class III trials, two reported statistically significant reductions in their primary efficacy measures.
The review’s conclusion: Grade C — possibly effective for migraine prevention.

The “Level B” rating often quoted comes from the 2012 AAN/AHS migraine prevention guideline. The review above grades it more cautiously, and the difference is worth noting.

Which dose, which form?

The 600 mg figure comes largely from a 1996 trial by Peikert. Participants took 600 mg (24 mmol) of trimagnesium dicitrate or placebo for 12 weeks. In weeks 9–12, attack frequency fell by 41.6% in the magnesium group and by 15.8% on placebo.

There is also a signal that form matters: a more recent systematic review reported that trimagnesium dicitrate at 600 mg/day significantly reduced attack frequency and severity versus placebo, while magnesium aspartate did not outperform placebo. The findings hold for a specific form and dose, not for magnesium in general.

Important: 600 mg is well above the 375 mg nutrient reference value and is an intervention dose used in trials, not a supplement serving. Whether to use it is a decision for your doctor. Magvela does not provide this dose and is not formulated for this purpose.

Which form to look at

The form that stands out in migraine research is magnesium citrate (trimagnesium dicitrate). That is a different form from the bisglycinate and taurate preferred in evening routines, and citrate is known to have a laxative effect at higher doses. The full comparison is in Magnesium forms compared.

When to see a doctor

Migraine is a diagnosis, and it is made by a clinician. A sudden headache that is the worst of your life, a headache with fever or neck stiffness, or one accompanied by vision loss, speech difficulty, weakness or altered consciousness needs emergency assessment. A change in the character or frequency of your headaches is also a reason to seek review.

Migraine prevention has evidence-based medical options. Magnesium does not replace them; it is something to consider alongside them, with your doctor.

Frequently asked

The questions most often searched on this topic, answered as they are.

How much magnesium per day was used in migraine trials?

The regimen that stands out is 600 mg of trimagnesium dicitrate daily. That is well above the 375 mg nutrient reference value and is an intervention dose used in research, not a supplement serving. Whether to use it is a clinical decision.

Does magnesium stop a headache or prevent one?

The trials examined preventive use aimed at reducing attack frequency, not at stopping a headache already underway. These are different questions with different approaches.

Is every form of magnesium the same here?

Not in this context. A recent systematic review found trimagnesium dicitrate significantly reduced attack frequency and severity versus placebo, while magnesium aspartate did not outperform placebo.

Is Magvela suitable for migraine?

Magvela is not formulated for this purpose and does not provide the trial dose above. Migraine is a diagnosis; prevention has evidence-based medical options and the decision belongs to your doctor or neurologist.

When is a headache an emergency?

A sudden headache that is the worst of your life; a headache with fever or neck stiffness; or one with vision loss, speech difficulty, weakness or altered consciousness requires emergency assessment. A change in character or frequency also warrants review.